In the latest issue of Marijuana Business Magazine, we went behind the scenes in some of the most innovative spaces in the marijuana and hemp industries. Click through this slideshow to see more photos from our visit to the Kazmira CBD company, a cannabis-trimming robot from Bloom Automation and an organic farm in Oregon that’s making inroads with a closed-loop cultivation system.

DEA takes some CBD medicines off Schedule 1
The U.S. Food and Drug Administration in June approved a naturally derived CBD drug, Epidiolex.
The landmark decision triggered a new classification for the cannabinoid from the Drug Enforcement Administration. The DEA announced that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, provided the medications have been approved by the FDA.
The U.S. Food and Drug Administration in June approved a naturally derived CBD drug, Epidiolex.
The landmark decision triggered a new classification for the cannabinoid from the Drug Enforcement Administration. The DEA announced that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, provided the medications have been approved by the FDA.